Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the owners of Qstar Försäljning AB and Card Network Solutions Europe AB on the sale to DCC Energi Sweden AB
Mandate

Vinge advises the owners of Qstar Försäljning AB and Card Network Solutions Europe AB on the sale to DCC Energi Sweden AB

July 17, 2014

Vinge advises the owners of Qstar Försäljning AB and Card Network Solutions Europe AB (CNS) on the sale of the companies to DCC Energi Sweden AB. Qstar Försäljning operates approx. 400 petrol stations across Sweden under the brands “Qstar”, “Bilisten” and “Pump”. CNS provides business systems and card solutions for the petrol and fuel industry. Qstar Försäljning is the fifth largest retail petrol station operator in Sweden, with a turnover of approx. MSEK 2,000 in 2013 and selling approx. 300 million litres of product per annum. The sale was completed on 9 May 2014.

Vinge’s team has included partner Johan Göthberg and associates Peter Sundgren, Karl Hahtovirta and Louise Nordkvist (M&A), Johan Cederblad (environmental), Fredrik Gustafsson (employment law) and Grant McKelvey (EU & competition law) as well as project assistant Pernilla Warg.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026